An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica
about
The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European CountriesBiotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study.Importance of Regular and Maintenance Therapy Adherence in Neuromyelitis Optica (NMO): Lessons from a Repeating Relapse Case.Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation.Treatment strategies for neuromyelitis optica
P2860
An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
An update on the evidence for ...... gement of neuromyelitis optica
@ast
An update on the evidence for ...... gement of neuromyelitis optica
@en
An update on the evidence for ...... gement of neuromyelitis optica
@nl
type
label
An update on the evidence for ...... gement of neuromyelitis optica
@ast
An update on the evidence for ...... gement of neuromyelitis optica
@en
An update on the evidence for ...... gement of neuromyelitis optica
@nl
prefLabel
An update on the evidence for ...... gement of neuromyelitis optica
@ast
An update on the evidence for ...... gement of neuromyelitis optica
@en
An update on the evidence for ...... gement of neuromyelitis optica
@nl
P2860
P356
P1476
An update on the evidence for ...... gement of neuromyelitis optica
@en
P2093
Jérôme de Seze
Nicolas Collongues
P2860
P304
P356
10.1177/1756285616632653
P407
P577
2016-03-23T00:00:00Z